Works matching IS 03125963 AND DT 2022 AND VI 61 AND IP 11

Results: 11

Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1609, doi. 10.1007/s40262-022-01179-2

By:

Thy, Michael;
Urien, Saik;
Bouazza, Naim;
Foissac, Frantz;
Gana, Inès;
Bille, Emmanuelle;
Béranger, Agathe;
Toubiana, Julie;
Berthaud, Romain;
Lesage, Fabrice;
Renolleau, Sylvain;
Tréluyer, Jean-Marc;
Benaboud, Sihem;
Oualha, Mehdi

Publication type:

Article

Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1641, doi. 10.1007/s40262-022-01178-3

By:

Montanha, Maiara Camotti;
Fabrega, Francesc;
Howarth, Alice;
Cottura, Nicolas;
Kinvig, Hannah;
Bunglawala, Fazila;
Lloyd, Andrew;
Denti, Paolo;
Waitt, Catriona;
Siccardi, Marco

Publication type:

Article

Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC–MS/MS Method.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1571, doi. 10.1007/s40262-022-01177-4

By:

Shi, Meiyun;
Yin, Lei;
Sun, Yantong;
Wang, Can;
Cai, Lanlan;
Zhang, Tinglan;
Zhou, Xiaotong;
Fawcett, J. Paul;
Gao, Xiaoli;
Gu, Jingkai

Publication type:

Article

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1595, doi. 10.1007/s40262-022-01175-6

By:

Nassar, Yomna M.;
Hohmann, Nicolas;
Michelet, Robin;
Gottwalt, Katharina;
Meid, Andreas D.;
Burhenne, Jürgen;
Huisinga, Wilhelm;
Haefeli, Walter E.;
Mikus, Gerd;
Kloft, Charlotte

Publication type:

Article

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1495, doi. 10.1007/s40262-022-01174-7

By:

Narendra, Gera;
Choudhary, Shalki;
Raju, Baddipadige;
Verma, Himanshu;
Silakari, Om

Publication type:

Article

The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1519, doi. 10.1007/s40262-022-01173-8

By:

Gatti, Milo;
Pea, Federico

Publication type:

Article

Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1623, doi. 10.1007/s40262-022-01172-9

By:

Zahir, Hamim;
Greenberg, Jonathan;
Shuster, Dale;
Hsu, Ching;
Watanabe, Kengo;
LaCreta, Frank

Publication type:

Article

Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1545, doi. 10.1007/s40262-022-01164-9

By:

Chu, Wan-Yu;
Allegaert, Karel;
Dorlo, Thomas P. C.;
Huitema, Alwin D. R.;
the ALBINO Study Group;
Franz, Axel R.;
Rüdiger, Mario;
Nijstad, Laura;
Annink, Kim;
Maiwald, Christian;
Schroth, Michael;
Hagen, Anja;
Bakkali, Loubna el;
van Weisenbruch, Mirjam M.;
Poets, Christian F.;
Benders, Manon;
van Bel, Frank;
Naulaers, Gunnar;
Bassler, Dirk;
Klebermass-Schrehof, Katrin

Publication type:

Article

Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1585, doi. 10.1007/s40262-022-01163-w

By:

Zou, Yuanxi;
Nedelman, Jerry;
Lombardi, Antonio;
Pappas, Frances;
Karlsson, Mats O.;
Svensson, Elin M.

Publication type:

Article

Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1559, doi. 10.1007/s40262-022-01162-x

By:

Jaspers, Tessa C. C.;
Meijer, Charlotte E.;
Vleming, Louis Jean;
Franssen, Casper F. M.;
Diepstraten, Jeroen;
Lukens, Michael V.;
van den Bemt, Patricia M. L. A.;
Maat, Barbara;
Khorsand, Nakisa;
Touw, Daniël J.;
Koomen, Jeroen V.

Publication type:

Article

Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib.

Published in:

Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1477, doi. 10.1007/s40262-022-01157-8

By:

Liao, Mingxiang;
Beltman, Jeri;
Giordano, Heidi;
Harding, Thomas C.;
Maloney, Lara;
Simmons, Andrew D.;
Xiao, Jim J.

Publication type:

Article